DNAprint Genomics (DNAG)

[sam1933]

FDA May Collaborate with Personal Genomics Firms to Track Adverse Events
[November 26, 2008]
By Turna Ray
Editor, Pharmacogenomics Reporter
http://www.genomeweb.com/issues/news/150968-1.html

…In marketing ancestry and disease-predisposition genetic testing services directly to consumers, personal genomics companies are building large electronic databases of clinical and genomic information that the FDA believes can be useful in tracking adverse drug reactions in a post-marketing setting.
“We’re interested in collaborating with them, if I can say that,” Lesko said at a pharmacogenomics conference sponsored by Genome Quebec earlier this month in Montreal…